SciQuus Oncology adds business strategy and development professional
May 27, 2014
Ms. Dorr has joined SciQuus to develop its position within the domestic and international CRO markets. She brings to SciQuus a fresh approach to business strategy, client acquisition, and marketing. Ms. Dorr comments, “I am excited to join SciQuus and look forward to working with the team to make SciQuus a known entity in the oncology-focused CRO and biotech fields. I am fortunate to join a team and company with such a wealth of experience in clinical research and small company management.”
Ms. Dorr holds an International MBA degree with a certificate in social, ethical, and environmental responsible (SEER) business from Pepperdine University’s Graziadio School of Business and Management. She comes to SciQuus with experience in consulting and biotech having previously worked at Kalypso, LP (2013), Proacta, Inc. (2011-2012), and Jenny Craig, Inc. (2010-2012). Ms. Dorr also holds a BA in French Studies from Wake Forest University, Winston-Salem, NC.
About SciQuus Oncology Incorporated
SciQuus Oncology is focused on providing clinical trial and drug development resources to the pharmaceutical and biopharmaceutical industries. SciQuus Oncology was formed and incorporated in late 2013 as a spin out from the clinical research division at Proacta Inc.